應用程式 | 微信預約
預約要求 | 網上預約
最新消息
-
2026-03-19
(19 March 2026, Hong Kong) HKSH Medical Group (HKSH) today announced the results of Asia’s first clinical study on early-stage prostate cancer patients receiving five-session of proton therapy.* The results show significant efficacy, with a marked decline in prostate-specific antigen (PSA) levels and only mild side effects. Proton therapy for prostate cancer generally requires... -
2026-03-03
(3 March, 2026 – Hong Kong) HKSH Medical Group (HKSH) and China Life Insurance (Overseas) Company Limited (CLIO) formed a strategic collaboration, with HKSH becoming the first healthcare institution in Hong Kong to offer personalised, end-to-end health management and medical concierge services for CLIO ENRICH’s topmost Diamond-tier clients. The comprehensive programme... -
2026-02-02
(2 February, 2026 – Hong Kong) HKSH Medical Group (HKSH) and The Hong Kong Polytechnic University (PolyU) today signed a collaborative agreement to provide diverse placement opportunities for PolyU’s pioneering Master of Science (MSc) in Dietetics programme – the first of its kind in Hong Kong, making HKSH the first private medical institution to offer clinical placement and... -
2025-12-30
(Hong Kong, 30 December, 2025) HKSH Medical Group (HKSH) and UCLA Health have long been committed to strengthening the professional competencies of nursing and allied healthcare personnel through continuous education, aiming to enhance the quality of clinical services. To commemorate the 15th anniversary of the collaboration, HKSH and UCLA Health signed a new three-year... -
2025-12-29
(29 December, 2025 – Hong Kong) HKSH Medical Group (“HKSH”) and Southern University of Science and Technology (“SUSTech”) officially signed a Memorandum of Understanding (“MOU”) on 15 December 2025, a significant initiative to deepen collaboration between Hong Kong and the Chinese Mainland in the fields of medicine and medical physics.
During the signing ceremony,...
